Literature DB >> 9837783

Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons.

T Saito1, K Ishiguro, R Onuki, Y Nagai, T Kishimoto, S Hisanaga.   

Abstract

Degradation of p35, a neuron-specific activator of CDK5, was studied in rat cortical neurons in primary culture. Treatment of cultured neurons with cyclohexamide induced the rapid disappearance of p35 accompanied by parallel inactivation of the kinase activity of CDK5. The disappearance of p35 was blocked with proteasome inhibitors benzyloxycarbonyl-leucyl-leucyl-leucinal and lactacystin, indicating the involvement of proteasome. The degradation of p35 was induced with okadaic acid in the presence of ATP in neuron extracts. The degradation of p35 by proteasome in cultured neurons was stimulated by okadaic acid in the absence of cyclohexamide. These results indicate that p35 is degraded by proteasome in a phosphorylation-dependent manner in neurons. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837783     DOI: 10.1006/bbrc.1998.9739

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

2.  Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta.

Authors:  Justin V Louis; Ellen Martens; Peter Borghgraef; Caroline Lambrecht; Ward Sents; Sari Longin; Karen Zwaenepoel; Robert Pijnenborg; Isabelle Landrieu; Guy Lippens; Birgit Ledermann; Jürgen Götz; Fred Van Leuven; Jozef Goris; Veerle Janssens
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

3.  Commitment of 1-methyl-4-phenylpyrinidinium ion-induced neuronal cell death by proteasome-mediated degradation of p35 cyclin-dependent kinase 5 activator.

Authors:  Ryo Endo; Taro Saito; Akiko Asada; Hiroyuki Kawahara; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

4.  Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

Authors:  Emmanuel Planel; Tomohiro Miyasaka; Thomas Launey; De-Hua Chui; Kentaro Tanemura; Shinji Sato; Ohoshi Murayama; Koichi Ishiguro; Yoshitaka Tatebayashi; Akihiko Takashima
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

5.  Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.

Authors:  Toshiyuki Takasugi; Seiji Minegishi; Akiko Asada; Taro Saito; Hiroyuki Kawahara; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

6.  Effects of p35 Mutations Associated with Mental Retardation on the Cellular Function of p35-CDK5.

Authors:  Shunsuke Takada; Keiko Mizuno; Taro Saito; Akiko Asada; Karl Peter Giese; Shin-Ichi Hisanaga
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

Review 7.  Physiological and pathological phosphorylation of tau by Cdk5.

Authors:  Taeko Kimura; Koichi Ishiguro; Shin-Ichi Hisanaga
Journal:  Front Mol Neurosci       Date:  2014-07-15       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.